Tag: Coronavirus information (COVID-19)
News
Janssen Inc Announces the Initiation of a Rolling Submission for its Single-dose Janssen COVID-19 Vaccine Candidate with Health Canada
Janssen Inc. the pharmaceutical companies of Johnson & Johnson, has initiated a rolling submission with Health Canada for its investigational single-dose vaccine candidate for...
News
EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2
EMA has received an application for conditional marketing authorisation (CMA) for BNT162b2, a COVID?19 mRNA vaccine developed by BioNTech and Pfizer. The assessment of...
News
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing with U.S. FDA for EUA
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that...
Drug Research
Moderna Announces Amendment to Current Supply Agreement with UK Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19
Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced...
News
Saudi Pharma in talks with Germanys CureVac for coronavirus shot
Saudi Pharmaceutical Industries and Medical Appliances Corp. have signed a non-binding memorandum of understanding with German biotech company CureVac NV to provide a Covid-19...
News
Recipharm announces signature of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate
Recipharm, a leading contract development and manufacturing organisation (CDMO) announces that it has signed a letter of intent with Moderna, a U.S. based biotech...
News
Patent Protection Lift-off For COVID-19 Vaccines; Not a Bright Choice
The world of Pharmaceuticals is caught in the web of who brings out the vaccine and when scenario. The darkest hours that the world...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read